{
    "clinical_study": {
        "@rank": "68941", 
        "acronym": "NIRF-C", 
        "arm_group": {
            "arm_group_label": "NIRF-C", 
            "arm_group_type": "Experimental", 
            "description": "Each subject enrolled in this study will undergo near-infrared cholangiography fluorescence (NIRF-C) and standard of care intraoperative cholangiography."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate an imaging system using Indocyanine Green (ICG) to\n      assist in real-time identification of anatomy during cholecystectomy (gallbladder removal).\n      We propose to define the effectiveness of NIRF-C in identifying the cystic duct junction\n      during cholecystectomy. Also, the knowledge gained from this study will be used in the\n      development of a novel microbubble/ICG compound, which will serve as a dual mode,\n      ultrasound/fluorescence imaging system for abdominal surgery."
        }, 
        "brief_title": "Near Infrared Fluorescence Cholangiography (NIRF-C) During Cholecystectomy", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Cholecystitis", 
        "condition_browse": {
            "mesh_term": [
                "Cholecystitis", 
                "Acalculous Cholecystitis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age 18-89\n\n          -  Planned laparoscopic cholecystectomy\n\n        Exclusion Criteria:\n\n          -  Inability to provide informed consent\n\n          -  Pregnant\n\n          -  Allergy to ICG, iodine, and/or shellfish\n\n          -  Acute cholecystitis, cholangitis, and/or cirrhosis (main study)\n\n          -  Lactating"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "89 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "102", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 21, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02070640", 
            "org_study_id": "2011H0239"
        }, 
        "intervention": [
            {
                "arm_group_label": "NIRF-C", 
                "description": "2.5 mg of of ICG will be injected intravenously 60-30 minutes prior to surgery. An additional 2.5 mg of IV ICG may be given intraoperatively if fluorescence has faded prior to visualization.", 
                "intervention_name": "Injection of indocyanine green (ICG)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "NIRF-C", 
                "description": "These devices are used to identify anatomy, using infrared light that causes the ICG to fluoresce.", 
                "intervention_name": "Near Infrared Cholangiography Fluorescence (NIRF-C)", 
                "intervention_type": "Device", 
                "other_name": [
                    "Stryker 1488 Camera System", 
                    "Stryker L9000 Light Source", 
                    "Stryker 1488 Coupler", 
                    "Stryker 10mm Ideal Eyes Laparoscope (0 and 30 degree)"
                ]
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "cholecystectomy", 
            "cholecystitis"
        ], 
        "lastchanged_date": "March 6, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Columbus", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "43214"
                }, 
                "name": "The Ohio State University Wexner Medical Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Near Infrared Fluorescence Cholangiography During Cholecystectomy", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "A patient's negative reaction to indocyanine green (ICG) will be monitored from the time of injection through the 2 week post-operative follow-up visit.", 
            "measure": "Complications related to ICG", 
            "safety_issue": "Yes", 
            "time_frame": "From time of injection to 1st post-op follow-up"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02070640"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ohio State University", 
            "investigator_full_name": "Narula, Vimal K, MD", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Incidence of anatomic identification with NIRF-C and intraoperative cholangiography will be used to calculate a 95% confidence interval for the effectiveness of this modality.", 
                "measure": "Incidence of anatomic identification with NIRF-C", 
                "safety_issue": "No", 
                "time_frame": "Intraoperative"
            }, 
            {
                "description": "The time required to complete NIRF-C and intraoperative cholangiography will be analyzed.", 
                "measure": "Time", 
                "safety_issue": "No", 
                "time_frame": "Intraoperative"
            }
        ], 
        "source": "Ohio State University", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Stryker Instruments", 
                    "agency_class": "Industry"
                }, 
                {
                    "agency": "Society of American Gastrointestinal and Endoscopic Surgeons", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Ohio State University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}